アジア太平洋地域の生体分析検査サービス市場は、2022 年に 10 億 433 万ドルと評価され、2030 年までに 22 億 5,288 万ドルに達すると予想されます。 2022 年から 2030 年までのCAGRは 10.6% と推定されます。
アジア太平洋地域の生体分析検査サービス市場は、中国、日本、インド、韓国、オーストラリア、およびその他のアジア太平洋地域に分割されています。アジア太平洋地域の生体分析検査サービス市場は、低コスト労働市場におけるアウトソーシングサービスの需要の増加により、調査期間中に最高の成長を遂げると予想されます。通常、インドネシア、インド、中国の配送センターが、この地域のアウトソーシング サービスをサポートしています。中国は、日本を拠点とするオンショアおよびオフショアの両方の顧客にとって配達場所として人気が高まっています。さらに、地域各国の政府は感染症の蔓延防止をますます重視しており、生体分析検査サービス市場の拡大に大きく貢献しています。たとえば、保健省、地元の大学、非政府組織 (NGO) は、この能力構築イニシアチブの継続的な支援と持続可能性を確保します。この実施研究訓練は、インド太平洋地域における監視と対応に基づく共同研究プロジェクトの広範なプログラムである「熱帯衛生パートナーズ」プロジェクトの一環として行われました。
目次
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioanalytical Testing Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Bioanalytical Testing Services Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
5.2.1 High Cost Associated to Bioanalytical Testing Services
5.3 Key Market Opportunities
5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:
6. Bioanalytical Testing Services Market - Asia Pacific Market Analysis
6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
7. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
7.3.1 Overview
7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
7.4.1 Overview
7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
7.5.1 Overview
7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
7.6.1 Overview
7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 In-Vitro Virology Testing
7.6.2.1.1 Overview
7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6.3 In-Vivo Virology Testing
7.6.3.1 Overview
7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
7.7.1 Overview
7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication
8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
8.3.1 Overview
8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
8.4.1 Overview
8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
8.7.1 Overview
8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
8.8.1 Overview
8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
8.9.1 Overview
8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
8.10.1 Overview
8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
9.4.1 Overview
9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development And Manufacturing Organization (CDMO)
9.5.1 Overview
9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioanalytical Testing Services Market - Country Analysis
10.1 Asia Pacific Bioanalytical Testing Services Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Asia Pacific Bioanalytical Testing Services Market by Country
10.1.1.2 China
10.1.1.2.1 Overview
10.1.1.2.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 China Bioanalytical Testing Services Market, by Services
10.1.1.2.3.1 China Bioanalytical Testing Services Market, by Virology Testing
10.1.1.2.4 China Bioanalytical Testing Services Market, by Disease Indication
10.1.1.2.5 China Bioanalytical Testing Services Market, by End User
10.1.1.3 Japan
10.1.1.3.1 Overview
10.1.1.3.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Japan Bioanalytical Testing Services Market, by Services
10.1.1.3.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
10.1.1.3.4 Japan Bioanalytical Testing Services Market, by Disease Indication
10.1.1.3.5 Japan Bioanalytical Testing Services Market, by End User
10.1.1.4 India
10.1.1.4.1 Overview
10.1.1.4.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 India Bioanalytical Testing Services Market, by Services
10.1.1.4.3.1 India Bioanalytical Testing Services Market, by Virology Testing
10.1.1.4.4 India Bioanalytical Testing Services Market, by Disease Indication
10.1.1.4.5 India Bioanalytical Testing Services Market, by End User
10.1.1.5 Australia
10.1.1.5.1 Overview
10.1.1.5.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Australia Bioanalytical Testing Services Market, by Services
10.1.1.5.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
10.1.1.5.4 Australia Bioanalytical Testing Services Market, by Disease Indication
10.1.1.5.5 Australia Bioanalytical Testing Services Market, by End User
10.1.1.6 South Korea
10.1.1.6.1 Overview
10.1.1.6.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 South Korea Bioanalytical Testing Services Market, by Services
10.1.1.6.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
10.1.1.6.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
10.1.1.6.5 South Korea Bioanalytical Testing Services Market, by End User
10.1.1.7 Rest of Asia Pacific
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
10.1.1.7.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
10.1.1.7.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
10.1.1.7.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User
11. Bioanalytical Testing Services Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 SGS SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Syneos Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ICON Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Intertek Group Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
